BMEA

Biomea Fusion, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-24

Figures on this page computed 2026-11-08 12:40 UTC

Last close

0.57USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-03-24

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-24
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-03-24
- 10-Q for 2025, filed 2026-08-05
The filing itself
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-Q for 2025, filed 2026-08-05
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital is the furthest below its sector's middle: 0.05 against 0.20 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

n/a

0.97x

n/a

0.06x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

2 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-24

Salesn/a
Its own average over 0 years.
Profit0.97x
Its own average over 7 years, -63.9M.
Free cash flown/a
Its own average over 5 years, -65.4M.
Debtn/a
Its own average over 1 year, 259.0K.
Price0.06x
Its own average over 6 years, 9. Market data, 2026-11-06

Price is furthest from its own average, at 0.06 times.

Profit is 0.97 times its own 7-year average; Price is 0.06 times its own 6-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-24

Sales against its own 0-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
The filing itself
Profit against its own 7-year average0.97
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
The filing itself
Free cash flow against its own 5-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
The filing itself
Debt against its own 1-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-121825
Reported in
USD
The filing itself
Price against its own 6-year average0.06Market data, 2026-11-06
Source
market
Taken on
2026-11-06
Reported in
USD